Literature DB >> 7395839

Effect of diazepam on the lower esophageal sphincter. A double-blind controlled study.

M J Rushnak, C M Leevy.   

Abstract

The effect of diazepam on the lower esophageal sphincter (LES) pressure was studied in a controlled randomized double-blind protocol. Twenty-five patients received intravenous saline, diazepam 5 mg. and diazepam 10 mg. on different days. Diazepam 5 mg. and diazepam 10 mg. caused a mean peak reduction in LES pressure of 18.9 and 37.8% respectively. The peak reduction in LES pressure was dose-related and lasted approximately seven minutes. Awareness of diazepam's ability to significantly lower LES pressure is needed to avoid the possibility of falsely diagnosing reflux by endoscopy. The mechanism whereby diazepam lowers LES pressure is not known, however, diazepam may be acting as a smooth muscle relaxant since myogenic influences have been implicated in the genesis of LES pressure.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7395839

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  11 in total

Review 1.  Gastroesophageal reflux disease and sleep disturbances.

Authors:  Yasuhiro Fujiwara; Tetsuo Arakawa; Ronnie Fass
Journal:  J Gastroenterol       Date:  2012-05-17       Impact factor: 7.527

2.  The effect of intravenous diazepam on esophageal motility in normal subjects.

Authors:  R M Reveille; J S Goff; K Hollstrom-Tarwater
Journal:  Dig Dis Sci       Date:  1991-08       Impact factor: 3.199

3.  Endoscopically assisted water perfusion esophageal manometry with minimal sedation: technique, indications, and implication on the clinical management.

Authors:  Rita Brun; Kyle Staller; Sofia Viner; Braden Kuo
Journal:  J Clin Gastroenterol       Date:  2011-10       Impact factor: 3.062

4.  Impact of psychiatric disorders on patient satisfaction after Nissen Fundoplication.

Authors:  Carla N Holcomb; Noah J Switzer; Anahita Jalilvand; Patricia Belle; Monet McNally; Kyle Perry
Journal:  Surg Endosc       Date:  2019-08-13       Impact factor: 4.584

5.  Body mass index and chronic unexplained gastrointestinal symptoms: an adult endoscopic population based study.

Authors:  P Aro; J Ronkainen; N J Talley; T Storskrubb; E Bolling-Sternevald; L Agréus
Journal:  Gut       Date:  2005-05-25       Impact factor: 23.059

6.  Evaluation of Esophageal Motility Utilizing the Functional Lumen Imaging Probe.

Authors:  Dustin A Carlson; Peter J Kahrilas; Zhiyue Lin; Ikuo Hirano; Nirmala Gonsalves; Zoe Listernick; Katherine Ritter; Michael Tye; Fraukje A Ponds; Ian Wong; John E Pandolfino
Journal:  Am J Gastroenterol       Date:  2016-10-11       Impact factor: 10.864

7.  Hypnotics and infections: disproportionality analysis of the U.S. Food & Drug Administration adverse event reporting system database.

Authors:  Long Meng; Jing Huang; Qin He; Yibei Zhao; Wenlong Zhao; Juntao Tan; Shusen Sun; Junqing Yang
Journal:  J Clin Sleep Med       Date:  2022-09-01       Impact factor: 4.324

8.  Risk of pneumonia with inhaled corticosteroid/long-acting β2 agonist therapy in chronic obstructive pulmonary disease: a cluster analysis.

Authors:  Rachael L DiSantostefano; Hao Li; David Hinds; Dmitry V Galkin; David B Rubin
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2014-05-07

9.  Risk factors for aspiration pneumonia after definitive chemoradiotherapy or bio-radiotherapy for locally advanced head and neck cancer: a monocentric case control study.

Authors:  Sadayuki Kawai; Tomoya Yokota; Yusuke Onozawa; Satoshi Hamauchi; Akira Fukutomi; Hirofumi Ogawa; Tsuyoshi Onoe; Tetsuro Onitsuka; Takashi Yurikusa; Akiko Todaka; Takahiro Tsushima; Yukio Yoshida; Yosuke Kito; Keita Mori; Hirofumi Yasui
Journal:  BMC Cancer       Date:  2017-01-17       Impact factor: 4.430

10.  Melatonin for the treatment of gastroesophageal reflux disease; protocol for a systematic review and meta-analysis.

Authors:  Chang Seok Bang; Young Joo Yang; Gwang Ho Baik
Journal:  Medicine (Baltimore)       Date:  2019-01       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.